In hepatocellular carcinoma, SIRT3 reduction promotes cyclin E2 lactylation, enhancing the proliferation and invasion of hepatocellular carcinoma cells (Jin et al., 2023). Here, CCNE2 is linked to hepatocellular carcinoma.